Osteoporosis Medications Linked to Acute Angle Closure Risk
TOPLINE:Using bisphosphonates, especially risedronate, in clients with osteoporosis is connected to a greater threat for severe angle closure however not open-angle glaucoma.METHOD:Scientist carried out a retrospective mate research study utilizing an across the country health claims database to evaluate whether using oral or intravenous bisphosphonates increased the threat for severe angle closure and open-angle glaucoma.An overall of 208,111 clients with osteoporosis from the United States who utilized bisphosphonates or raloxifene (selected as the recommendation drug) from 2010 to 2018 were consisted of.Clients with intense angle closure and open-angle glaucoma were determined utilizing diagnostic codes; clients without these medical diagnoses were designated as the control group.The a...